Optimizing Care for Older Adults Through Thyroid Hormone Deprescribing
a study on Hypothyroidism
Summary
- Eligibility
- for people ages 65 years and up (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
Description
Summary
The proposed study focuses on testing a novel adapted evidence-based multilevel intervention, Deprescribing Thyroid Hormone In Older Adults (D-THIO), to support thyroid hormone deprescribing (dose de-escalation and/or discontinuation) in older adults with thyroid hormone overtreatment and/or misuse and reduce patient harm. Findings from this study will lay the groundwork for broad implementation of D-THIO and serve as a model for deprescribing inappropriate medications for other endocrine conditions and conditions with biochemical monitoring.
Details
The proposed study is the first multi-site trial to evaluate a novel evidence-based adapted multilevel intervention, D-THIO (Deprescribing Thyroid Hormone In Older Adults), consisting of evidence-based pharmaceutical opinion to providers, education brochures to patients and facilitated by clinical champions, to support thyroid hormone deprescribing in older adults. We will conduct a type 1 hybrid effectiveness-implementation trial of D-THIO vs. enhanced usual care (American Thyroid Association [ATA] provider abbreviated guidelines, ATA patient brochure) at 3 sites (University of Michigan, Henry Ford, University of California San Francisco) in 150 providers (primary care, endocrinologists, geriatricians, advance practice providers) and 750 of their patients 65 years and older who are overtreated with thyroid hormone. We will randomize 1:1 at the provider level within each site. The aims of the study are: 1) to assess the effectiveness of D-THIO on thyroid hormone deprescribing by providers and on reducing overtreatment and misuse with thyroid hormone via EMR, 2) to assess the effectiveness of D-THIO on provider and patient knowledge and attitudes regarding thyroid hormone deprescribing via surveys, and 3) to identify factors related to the implementation of D-THIO across diverse general care settings via post-trial interviews with key stakeholders.
Keywords
Hypothyroidism, thyroid hormone overtreatment and misuse, older adults, deprescribing, Hormones, D-THIO (Deprescribing Thyroid Hormone In Older Adults)
Eligibility
For people ages 65 years and up
Patient Eligibility:
Inclusion Criteria:
- age 65 years and older
- on thyroid hormone therapy and have a serum Thyroid-stimulating hormone (TSH) <0.5 mIU/L or are on thyroid hormone therapy for an inappropriate indication
- English speaking
- without cognitive impairment
Exclusion Criteria:
1) Patients with a diagnosis of thyroid cancer, secondary hypothyroidism, history of total thyroidectomy or hospitalization in the past 3 months will be excluded.
Provider eligibility:
Inclusion: Primary care physicians, endocrinologists, geriatricians, and Advanced Practice Providers (APPs) who practice at University of Michigan, Henry Ford Health System or University of California San Fransico (UCSF) and who prescribe thyroid hormone for eligible patients identified above will be eligible for study participation.
Exclusion: Providers who don't prescribe thyroid hormone.
Locations
- University of California San Francisco
accepting new patients
San Francisco California 94143 United States - University of Michigan
accepting new patients
Ann Arbor Michigan 48109 United States - Henry Ford Health System
accepting new patients
Detroit Michigan 48202 United States
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of Michigan
- ID
- NCT06629272
- Study Type
- Interventional
- Participants
- Expecting 900 study participants
- Last Updated